PABPATRYS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 27 July 2026, 18:28 | Investor Presentation - TechKnow Invest Roadshow | Presentations | MS | 03026 | |
| 22 July 2026, 19:35 | Appendix 4C - Quarterly - 30 June 2026 | Quarterly Reports | MS | 19004, 19009 | |
| 16 July 2026, 04:13 | Cleansing Notice | Securities Administration | — | 06018 | |
| 16 July 2026, 04:12 | Notification regarding unquoted securities - PAB | Other | — | 06021 | |
| 16 July 2026, 04:08 | Application for quotation of securities - PAB | Other | — | 06020 | |
| 13 July 2026, 18:22 | Patrys Secures 50% Revenue Share in IP Commercialisation | Company Update | MS | 11001 | |
| 8 July 2026, 04:14 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 4 July 2026, 04:14 | Change of Director's Interest Notices x4 | Director Interests | — | 02009 | |
| 4 July 2026, 04:11 | Notification regarding unquoted securities - PAB | Other | — | 06021 | |
| 4 July 2026, 04:09 | Cleansing Notice | Securities Administration | — | 06018 | |
| 4 July 2026, 04:06 | Application for quotation of securities - PAB | Other | — | 06020 | |
| 9 June 2026, 18:28 | Proposed issue of securities - PAB | Securities Administration | — | 06013 | |
| 9 June 2026, 18:26 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 20 May 2026, 19:31 | Patrys advances RLS-2202 toward Phase 1 Clinical Trial | Company Update | MS | 11001 | |
| 16 May 2026, 04:20 | Appendix 4C - Quarterly - 31 March 2026 - Updated | Quarterly Reports | — | 19003, 19008 | |
| 6 May 2026, 18:17 | Letter to Shareholders - General Meeting | Meetings & Governance | — | 08006, 16002 | |
| 6 May 2026, 18:17 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 30 Apr 2026, 19:13 | Appendix 4C - Quarterly - 31 March 2026 | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 18:48 | Cleansing Notice | Securities Administration | — | 06018 | |
| 29 Apr 2026, 18:44 | Application for quotation of securities - PAB | Other | — | 06020 | |
| 20 Apr 2026, 19:31 | Proposed issue of securities - PAB | Securities Administration | — | 06013 | |
| 20 Apr 2026, 19:31 | $3.2 million Placement to Advance Clinical Trials | Capital Raising | MS | 06003, 09014 | |
| 16 Apr 2026, 18:53 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 31 Mar 2026, 19:21 | Investor Presentation - Broker Meets Biotech | Presentations | MS | 03026 | |
| 19 Mar 2026, 06:36 | Notification of cessation of securities - PAB | Other | — | 06027 | |
| 14 Mar 2026, 05:34 | Change of Share Registry Details | Securities Administration | — | 12004 | |
| 11 Mar 2026, 19:23 | RLS-2201 Manufacturing and Regulatory Pathway Initiated | Company Update | MS | 11001 | |
| 27 Feb 2026, 05:12 | Appendix 4D - Half Year Accounts - 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 16 Feb 2026, 19:13 | CEO Commences Role | Company Administration | — | 12008 | |
| 12 Feb 2026, 19:13 | Appointment of Chief Executive Officer | Other | MS | 12019 | |
| 11 Feb 2026, 06:17 | Change of Director's Interest Notice - BL | Director Interests | — | 02009 | |
| 11 Feb 2026, 06:11 | Cleansing Notice | Securities Administration | — | 06018 | |
| 11 Feb 2026, 06:10 | Notification regarding unquoted securities - PAB | Other | — | 06021 | |
| 11 Feb 2026, 06:05 | Application for quotation of securities - PAB | Other | — | 06020 | |
| 3 Feb 2026, 05:31 | Initial Director's Interest Notice x2 | Director Interests | — | 02008 | |
| 30 Jan 2026, 19:17 | Appendix 4C - Quarterly - 31 December 2025 | Quarterly Reports | MS | 19002, 19007 | |
| 29 Jan 2026, 19:18 | Notification regarding unquoted securities - PAB | Other | — | 06021 | |
| 29 Jan 2026, 19:18 | Application for quotation of securities - PAB | Other | — | 06020 | |
| 29 Jan 2026, 19:17 | Cleansing Prospectus | Securities Administration | — | 06010 | |
| 28 Jan 2026, 20:37 | Investor Presentation | Mergers & Acquisitions | MS | 03026, 07001 | |
| 28 Jan 2026, 20:36 | Completion of Acquisition and Board Appointments | Mergers & Acquisitions | MS | 07001, 12001 | |
| 20 Jan 2026, 06:38 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 13 Dec 2025, 06:55 | Letter to Shareholders - General Meeting | Meetings & Governance | — | 08006, 16002 | |
| 13 Dec 2025, 06:51 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 26 Nov 2025, 20:14 | Pipeline Expanded with Proprietary Injectable Antipsychotic | Mergers & Acquisitions | MS | 07001, 09014, 11001 | |
| 24 Nov 2025, 20:04 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 11 Nov 2025, 00:29 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 11 Nov 2025, 00:25 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 10 Nov 2025, 20:03 | Changes to Board, Company Secretary and Office Address | Company Administration | — | 12001, 12002, 12003, 12007 | |
| 30 Oct 2025, 20:53 | Appendix 4C - Quarterly - 30 September 2025 | Quarterly Reports | MS | 19001, 19006 |
1–50 of 81
1 / 2